116 related articles for article (PubMed ID: 28571522)
1. Risk factors predicting the survival of pediatric patients with relapsed/refractory non-Hodgkin lymphoma who underwent hematopoietic stem cell transplantation: a retrospective study from the Turkish pediatric bone marrow transplantation registry.
Hazar V; Kesik V; Karasu GT; Öztürk G; Küpesiz A; Kılıç SÇ; Ataş E; Uygun V; Eker N; Erbey F; Bengoa ŞY; Emir S; Anak S; Öniz H; Daloğlu H; Aksoylar S; Koçak Ü; Karakükçü M; Elli M; Kurucu N; Yeşilipek A
Leuk Lymphoma; 2018 Jan; 59(1):85-96. PubMed ID: 28571522
[TBL] [Abstract][Full Text] [Related]
2. Outcome of pediatric patients with lymphoma following stem cell transplant: a single institution report.
Sumaili H; Al-Kofide A; Al-Seraihi A; Ayas M; Siddiqui K; El-Solh H; Al-Jefri A; Al-Ahmari A; Mohamed A; Anas M; Belgaumi AF
Leuk Lymphoma; 2015 May; 56(5):1327-34. PubMed ID: 25139691
[TBL] [Abstract][Full Text] [Related]
3. Intensive chemotherapy with hematopoietic stem-cell support for children with recurrent or refractory NHL.
Sandlund JT; Bowman L; Heslop HE; Krance R; Mahmoud H; Pui C-; Hale G; Benaim E
Cytotherapy; 2002; 4(3):253-8. PubMed ID: 12194721
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic hematopoietic stem cell transplant for relapsed and refractory non-Hodgkin lymphoma in pediatric patients.
Naik S; Martinez CA; Omer B; Sasa G; Yassine K; Allen CE; Kamdar K; Orth R; Wu M; Leung K; Gottschalk S; Brenner MK; Heslop HE; Krance RA
Blood Adv; 2019 Sep; 3(18):2689-2695. PubMed ID: 31511228
[TBL] [Abstract][Full Text] [Related]
5. Ten-year follow-up of pediatric patients with non-Hodgkin lymphoma treated with allogeneic or autologous stem cell transplantation.
Giulino-Roth L; Ricafort R; Kernan NA; Small TN; Trippett TM; Steinherz PG; Prockop SE; Scaradavou A; Chiu M; O'Reilly RJ; Boulad F
Pediatr Blood Cancer; 2013 Dec; 60(12):2018-24. PubMed ID: 24038967
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents.
Gross TG; Hale GA; He W; Camitta BM; Sanders JE; Cairo MS; Hayashi RJ; Termuhlen AM; Zhang MJ; Davies SM; Eapen M
Biol Blood Marrow Transplant; 2010 Feb; 16(2):223-30. PubMed ID: 19800015
[TBL] [Abstract][Full Text] [Related]
7. Ifosfamide, idarubicin, and etoposide in relapsed/refractory Hodgkin disease or non-Hodgkin lymphoma: a salvage regimen with high response rates before autologous stem cell transplantation.
Oyan B; Koc Y; Ozdemir E; Kars A; Turker A; Tekuzman G; Kansu E
Biol Blood Marrow Transplant; 2005 Sep; 11(9):688-97. PubMed ID: 16125639
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic stem cell transplantation in children and adolescents with relapsed or refractory B-cell non-Hodgkin lymphoma.
Fujita N; Kobayashi R; Atsuta Y; Iwasaki F; Suzumiya J; Sasahara Y; Inoue M; Koh K; Hori T; Goto H; Ichinohe T; Hashii Y; Kato K; Suzuki R; Mitsui T
Int J Hematol; 2019 Apr; 109(4):483-490. PubMed ID: 30701466
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic stem cell transplantation using lymphoablative rather than myeloablative conditioning regimen for relapsed or refractory lymphomas.
Yoon JH; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Lee JW; Min WS; Cho SG
Hematol Oncol; 2017 Mar; 35(1):17-24. PubMed ID: 25782369
[TBL] [Abstract][Full Text] [Related]
10. Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission.
Vose JM; Rizzo DJ; Tao-Wu J; Armitage JO; Bashey A; Burns LJ; Christiansen NP; Freytes CO; Gale RP; Gibson J; Giralt SA; Herzig RH; Lemaistre CF; McCarthy PL; Nimer SD; Petersen FB; Schenkein DP; Wiernik PH; Wiley JM; Loberiza FR; Lazarus HM; van Biesen K; Horowitz MM
Biol Blood Marrow Transplant; 2004 Feb; 10(2):116-27. PubMed ID: 14750077
[TBL] [Abstract][Full Text] [Related]
11. Yttrium-90 ibritumomab tiuxetan (Zevalin) followed by BEAM (Z-BEAM) conditioning regimen and autologous stem cell transplantation (ASCT) in relapsed or refractory high-risk B-cell non-Hodgkin lymphoma (NHL): a single institution Italian experience.
Ciochetto C; Botto B; Passera R; Bellò M; Benevolo G; Boccomini C; Castellino A; Chiappella A; Freilone R; Nicolosi M; Orsucci L; Pecoraro C; Pregno P; Bisi G; Vitolo U
Ann Hematol; 2018 Sep; 97(9):1619-1626. PubMed ID: 29663029
[TBL] [Abstract][Full Text] [Related]
12. Autologous peripheral blood stem cell transplantation in children with non-Hodgkin's lymphoma: A report from the Korean society of pediatric hematology-oncology.
Won SC; Han JW; Kwon SY; Shin HY; Ahn HS; Hwang TJ; Yang WI; Lyu CJ
Ann Hematol; 2006 Nov; 85(11):787-94. PubMed ID: 16932891
[TBL] [Abstract][Full Text] [Related]
13. Outcome analysis of high-dose chemotherapy and autologous stem cell transplantation in adolescent and young adults with relapsed or refractory Hodgkin lymphoma.
Akhtar S; Rauf SM; Elhassan TA; Maghfoor I
Ann Hematol; 2016 Sep; 95(9):1521-35. PubMed ID: 27376363
[TBL] [Abstract][Full Text] [Related]
14. Outcome of autologous hematopoietic stem cell transplantation in children and adolescents with relapsed or refractory Hodgkin's lymphoma.
Hazar V; Kesik V; Aksoylar S; Karakukcu M; Ozturk G; Kupesiz A; Atas E; Oniz H; Kansoy S; Unal E; Tanyeli A; Erbey F; Elli M; Tacyildiz N; Karasu GT; Kocak U; Anak S; Yilmaz Bengoa S; Sezgin G; Atay D; Unal E; Uygun V; Kurucu N; Kaya Z; Yesilipek A;
Pediatr Transplant; 2015 Nov; 19(7):745-52. PubMed ID: 26346042
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic haematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphoma.
Doocey RT; Toze CL; Connors JM; Nevill TJ; Gascoyne RD; Barnett MJ; Forrest DL; Hogge DE; Lavoie JC; Nantel SH; Shepherd JD; Sutherland HJ; Voss NJ; Smith CA; Song KW
Br J Haematol; 2005 Oct; 131(2):223-30. PubMed ID: 16197454
[TBL] [Abstract][Full Text] [Related]
16. Influence of preparatory regimen and source of hematopoietic cells on outcome of autotransplantation for non-Hodgkin's lymphoma.
Stockerl-Goldstein KE; Horning SJ; Negrin RS; Chao NJ; Hu WW; Long GD; Hoppe RT; Amylon MD; Brown BW; Wong RM; Blume KG
Biol Blood Marrow Transplant; 1996 May; 2(2):76-85. PubMed ID: 9118302
[TBL] [Abstract][Full Text] [Related]
17. [Autologous stem-cell transplantations in children with non-Hodgkin lymphomas].
Wójcik B; Kowalczyk JR; Chybicka A; Wachowiak J; Drabko K; Zaucha-Prazmo A; Choma M; Gorczyńska E; Toporski J; Turkiewicz D; Kałwak K; Pieczonka A; Boruczkowski D
Przegl Lek; 2004; 61 Suppl 2():53-6. PubMed ID: 15686047
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Factors and a New Prognostic Index Model for Children and Adolescents with Hodgkin's Lymphoma Who Underwent Autologous Hematopoietic Stem Cell Transplantation: A Multicenter Study of the Turkish Pediatric Bone Marrow Transplantation Study Group.
Kesik V; Ataş E; Karakükcü M; Aksoylar S; Erbey F; Taçyıldız N; Küpesiz A; Öniz H; Ünal E; Kansoy S; Öztürk G; Elli M; Kaya Z; Ünal E; Hazar V; Yılmaz Bengoa Ş; Karasu G; Atay D; Dağdemir A; Ören H; Koçak Ü; Yeşilipek MA
Turk J Haematol; 2016 Dec; 33(4):265-272. PubMed ID: 27094103
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic stem cell transplantation does not increase the risk of infection-related complications for pediatric patients with Hodgkin and non-Hodgkin lymphomas: A multicenter nationwide study.
Zając-Spychała O; Wachowiak J; Czyżewski K; Dziedzic M; Wysocki M; Zalas-Więcek P; Szmydki-Baran A; Hutnik Ł; Matysiak M; Małas Z; Badowska W; Gryniewicz-Kwiatkowska O; Gietka A; Dembowska-Bagińska B; Semczuk K; Dzierżanowska-Fangrat K; Bartnik M; Ociepa T; Urasiński T; Frączkiewicz J; Salamonowicz M; Kałwak K; Gorczyńska E; Chybicka A; Irga-Jaworska N; Bień E; Drożyńska E; Chełmecka-Wiktorczyk L; Balwierz W; Zak I; Pierlejewski F; Młynarski W; Urbanek-Dądela A; Karolczyk G; Stolpa W; Sobol-Milejska G; Płonowski M; Krawczuk-Rybak M; Musiał J; Chaber R; Gamrot-Pyka Z; Woszczyk M; Tomaszewska R; Szczepański T; Kowalczyk J; Styczyński J
Transpl Infect Dis; 2020 Aug; 22(4):e13292. PubMed ID: 32285579
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic stem cell transplantation for non-Hodgkin lymphoma.
Bhatt VR; Vose JM
Hematol Oncol Clin North Am; 2014 Dec; 28(6):1073-95. PubMed ID: 25459180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
